NCT05078866 2026-03-03Cancer Preventive Vaccine Nous-209 for Lynch Syndrome PatientsNational Cancer Institute (NCI)Phase 1/2 Active not recruiting45 enrolled
NCT02911142 2025-07-28Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell LymphomaNational Institutes of Health Clinical Center (CC)Phase 1/2 Active not recruiting17 enrolled 21 charts